v3.26.1
Segment and Geographic Information (Tables)
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of segment profit or loss, including significant segment expenses
The table below is a summary of the segment profit or loss, including significant segment expenses (in thousands):
Three months ended June 30,Six months ended June 30,
2026202520262025
Net product revenue - U.S.$50,987 $31,982 $87,883 $56,352 
Net product revenue - International20,268 16,520 43,484 29,868 
Total net product revenue 71,255 48,502 131,367 86,220 
License revenue- - — (5,014)
Total revenue, net 71,255 48,502 131,367 81,206 
Cost of sales8,931 5,543 16,088 9,191 
Global headcount expense 59,446 39,892 118,100 74,760 
Preclinical, clinical and development expense 20,311 22,946 38,822 42,906 
Commercial & medical affairs 21,879 17,030 42,143 30,279 
Corporate, general & administrative 9,240 8,387 17,127 16,370 
Other income (expense), net1,018 1,576 (686)932 
Interest income (expense), net(1,320)(2,575)(2,349)(4,345)
Income taxes 444 337 989 417 
Net loss $(49,298)$(46,632)$(104,937)$(96,130)
Schedule of revenue by geographic area
The Company allocates, for the purpose of geographic data reporting, its revenue based upon the location of its customers. Total product revenue, net, by geographic area was as follows (in thousands):
Three months ended June 30,Six months ended June 30,
2026202520262025
US $50,987 $31,982 $87,883 $56,352 
International20,268 16,520 43,484 29,868 
Total product revenue, net$71,255 $48,502 $131,367 $86,220